| scholarly article | Q13442814 |
| P50 | author | Kerby Shedden | Q73554789 |
| P2093 | author name string | Cheng Li | |
| Peter Ouillette | |||
| Sami N Malek | |||
| Jinghui Li | |||
| Roxane Collins | |||
| Sajid Shakhan | |||
| P2860 | cites work | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| 13q14 deletions in CLL involve cooperating tumor suppressors | Q24618669 | ||
| Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice | Q24675006 | ||
| Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 | ||
| B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions | Q28201835 | ||
| Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus | Q28203437 | ||
| Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia | Q28206302 | ||
| Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia | Q28208319 | ||
| Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia | Q28212879 | ||
| Chronic lymphocytic leukemia | Q28236621 | ||
| dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data | Q30899629 | ||
| A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia | Q33515409 | ||
| Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks. | Q33638819 | ||
| Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. | Q33931840 | ||
| Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia | Q33997232 | ||
| National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment | Q34382878 | ||
| Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia | Q34450715 | ||
| Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. | Q34575412 | ||
| Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus | Q36547675 | ||
| Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia | Q36843780 | ||
| Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression | Q37554072 | ||
| Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. | Q40123066 | ||
| Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. | Q40526270 | ||
| Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia | Q41104512 | ||
| 13q deletions in lymphoid malignancies | Q41302522 | ||
| Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia | Q43727628 | ||
| Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. | Q51647676 | ||
| Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3. | Q52528580 | ||
| 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. | Q53283792 | ||
| Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia | Q57234164 | ||
| Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82 midwestern patients | Q67538902 | ||
| Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities | Q68535307 | ||
| High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics | Q70656710 | ||
| Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia | Q71692445 | ||
| Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias | Q72110995 | ||
| A transcription map of the minimally deleted region from 13q14 in B-cell chronic lymphocytic leukemia as defined by large scale sequencing of the 650 kb critical region | Q73318797 | ||
| Characterization of a novel B-CLL candidate gene--DLEU7--located in the 13q14 tumor suppressor locus | Q75224028 | ||
| Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA) | Q79611680 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| lymphocyte | Q715347 | ||
| P304 | page(s) | 6778-6790 | |
| P577 | publication date | 2011-09-02 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia | |
| P478 | volume | 17 |
| Q33818637 | Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants |
| Q38798801 | Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas |
| Q39004167 | Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia |
| Q35140116 | BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia |
| Q58041435 | Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion |
| Q39263974 | Chronic lymphocytic leukaemia genomics and the precision medicine era. |
| Q43763021 | Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH. |
| Q38708220 | Chronic lymphocytic leukemia: Time to go past genomics? |
| Q36906625 | Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia |
| Q58277186 | Combined somatic mutation and copy number analysis in the survival of familial CLL |
| Q89985190 | Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients |
| Q34671934 | Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. |
| Q33364071 | Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle. |
| Q38819164 | Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets |
| Q33744997 | Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go |
| Q37697850 | Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness |
| Q36737322 | Genomic approaches to chronic lymphocytic leukemia |
| Q44882002 | Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. |
| Q61805367 | Genomic instability in a chronic lymphocytic leukemia patient with mono-allelic deletion of the and genes |
| Q87092957 | Guidelines for genomic array analysis in acquired haematological neoplastic disorders |
| Q89663745 | IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling |
| Q47360579 | Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada |
| Q37037294 | Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia |
| Q59413154 | Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: Different genetic mechanisms but equivalent poorer clinical outcome |
| Q58725483 | Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy |
| Q54198378 | Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia. |
| Q37164030 | Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells |
| Q36433299 | Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K). |
| Q47739621 | Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma |
| Q36421804 | Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia |
| Q47305053 | Retinoblastoma 1 protects T cell maturation from premature apoptosis by inhibiting E2F1. |
| Q38947537 | SNP Array in Hematopoietic Neoplasms: A Review |
| Q46087353 | Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities. |
| Q35861964 | TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells |
| Q37974664 | Telomere dysfunction and its role in haematological cancer. |
| Q27024411 | The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia |
| Q38286344 | The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications |
| Q38748645 | The molecular pathogenesis of chronic lymphocytic leukaemia |
| Q39551053 | The non-coding oncogene: a case of missing DNA evidence? |
| Q50703435 | The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study. |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q54977441 | Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why. |
Search more.